Study of TJ004309 in Combination With Atezolizumab (Tecentriq®) in Patients With Advanced or Metastatic Cancer

NCT03835949 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Tumor
Metastatic Cancer

Interventions

DRUG: TJ004309
DRUG: Atezolizumab

Sponsor

Tracon Pharmaceuticals Inc.